JP2002293703A - Indicator for heat-evaporation agent - Google Patents
Indicator for heat-evaporation agentInfo
- Publication number
- JP2002293703A JP2002293703A JP2001199091A JP2001199091A JP2002293703A JP 2002293703 A JP2002293703 A JP 2002293703A JP 2001199091 A JP2001199091 A JP 2001199091A JP 2001199091 A JP2001199091 A JP 2001199091A JP 2002293703 A JP2002293703 A JP 2002293703A
- Authority
- JP
- Japan
- Prior art keywords
- medicine
- color
- indicator
- layer
- mark
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は、主として薬剤加熱
蒸散容器にセットし、加熱蒸散薬剤の薬剤始点、薬剤終
点を表示する加熱蒸散薬剤用インジケータに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an indicator for a heat-evaporated medicine which is set in a medicine heat-evaporation container and displays the starting point and the end point of the heat-evaporated medicine.
【０００２】[0002]
【従来の技術】薬剤加熱蒸散容器に加熱蒸散薬剤を設
け、発熱体で加熱蒸散薬剤を加熱して蒸散する薬剤加熱
蒸散装置が種々提案されている。この薬剤加熱蒸散装置
においては、薬剤加熱蒸散容器にインジケータをセット
し、このインジケータで薬剤の始点と薬剤の終点を表示
し、薬剤の薬効成分が消滅したことを使用者が認識でき
るようにしている。2. Description of the Related Art There have been proposed various drug heating and evaporating apparatuses in which a heating and evaporating agent is provided in a heating and evaporating container, and the heating and evaporating agent is heated and evaporated by a heating element. In this drug heating and evaporation device, an indicator is set on the drug heating and evaporation container, and the start point and the end point of the drug are displayed on the indicator so that the user can recognize that the medicinal component of the drug has disappeared. .
【０００３】前述のインジケータとしては、加熱するこ
とで変色する物、例えば特開昭５５−１５２０５９号公
報に示す熱変色性積層物を用い、加熱時間の経過ととも
に無色から着色に変化させ、その変色と薬剤の薬効成分
の消滅（薬剤終点）を合わせたものが提案されている。
また、変色を利用して「おわり」の文字を表示したり、
シート全体が終点色に変色するようにしたインジケータ
が提案されている。As the above-mentioned indicator, a material which changes color upon heating, for example, a thermochromic laminate shown in JP-A-55-152059, is used. And the disappearance of the medicinal component (drug end point) of the drug have been proposed.
You can also use the discoloration to display the word "end"
An indicator has been proposed in which the entire sheet changes color to the end point color.
【０００４】[0004]
【発明が解決しようとする課題】前述のように、無色か
ら着色への変色、別の色への変色だけでは、薬剤終点の
時の色、つまり終点色の判別があいまいで分かり難く、
使用者が薬剤の薬効成分が消滅したことを認識し難い。As described above, the color at the time of the end point of the medicine, that is, the color of the end point is ambiguous and difficult to understand simply by changing the color from colorless to colored or changing to another color.
It is difficult for the user to recognize that the medicinal component of the drug has disappeared.
【０００５】そこで、本発明は前述の課題を解決できる
ようにした加熱蒸散薬剤用インジケータを提供すること
を目的とする。Accordingly, an object of the present invention is to provide an indicator for a heat-evaporated medicine capable of solving the above-mentioned problems.
【０００６】[0006]
【課題を解決するための手段】第１の発明は、加熱によ
る不可逆反応で起こる色変化を利用した薬剤使用期限を
表示するインジケータであって、前記色変化によって、
視認可能なマークを視認不可能なマークへ、視認不可能
なマークを視認可能なマークへ、の二つの変化を同時に
起こすことで、薬剤始点から薬剤終点に到る経過ととも
に薬剤使用状態を表現することを特徴とする加熱蒸散薬
剤用インジケータである。Means for Solving the Problems A first aspect of the present invention is an indicator for displaying the expiration date of a medicine utilizing a color change caused by an irreversible reaction due to heating.
Simultaneously causing two changes, a visible mark to an invisible mark and an invisible mark to a visible mark, expresses the state of use of the drug with the progress from the drug start point to the drug end point. An indicator for a heat-evaporated medicine, characterized in that:
【０００７】第２の発明は、第１の発明において、視認
可能から視認不可能へ変化する第１のマークが薬剤終点
色で表現され、視認不可能から視認可能へ変化する第２
のマークが薬剤始点色で表現された加熱蒸散薬剤用イン
ジケータである。According to a second aspect of the present invention, in the first aspect, the first mark that changes from visible to invisible is represented by a medicine end point color, and the second mark changes from invisible to visible.
Is an indicator for a heat-evaporated medicine represented by a medicine starting point color.
【０００８】第３の発明は、第１又は第２の発明におい
て、前記色変化は、突然ではなく加熱時間の経過に伴っ
て徐々に進行する加熱蒸散薬剤用インジケータである。A third aspect of the present invention is the heat-evaporating chemical indicator according to the first or second aspect, wherein the color change is not sudden but progresses gradually with the elapse of the heating time.
【０００９】第４の発明は、第１の発明において、変色
物質を保持した変色層を挟持する形で、表側に、５〜３
０ミクロンの透明フィルムを基材とした印刷層、裏側に
隠蔽性の高い５０ミクロン以上の不透明フィルムを基材
としたベース層でフィルムラミネート構成とした加熱蒸
散薬剤用インジケータである。A fourth aspect of the present invention is the liquid crystal display device according to the first aspect, in which a color-changing layer holding a color-changing substance is sandwiched between 5 to 3 on the front side.
This is an indicator for a heat-evaporating chemical having a film-laminated structure comprising a printing layer having a 0-micron transparent film as a base material and a base layer having an opaque film having a high concealability of 50 μm or more on the back side.
【００１０】[0010]
【作 用】第１の発明によれば、インジケータ中に、視
認可能なマークが視認不可能なマークへ変化して消滅し
ていく第１のマークと、視認不可能なマークが視認可能
なマークへ変化して現出してくる第２のマークの、二つ
のマークが存在するため、薬剤終点となって薬効成分が
消滅したことを使用者がはっきりと認識できる。According to the first invention, the first mark in which the visible mark changes to the invisible mark and disappears in the indicator, and the invisible mark is visible in the indicator. Since there are two marks of the second mark that appear after the change, the user can clearly recognize that the medicinal component has disappeared at the end point of the medicine.
【００１１】第２の発明によれば、第１のマークと第２
のマークの視認上の変化で薬剤終点となって薬効成分が
消滅したことを使用者がはっきりと認識できる。According to the second invention, the first mark and the second mark
The user can clearly recognize that the medicinal component has disappeared as a result of the visual change of the mark indicating the end point of the medicine.
【００１２】第３の発明によれば、加熱時間の経過に伴
って、徐々に第１のマークが消滅し、第２のマークが現
出してくる変化を観察することで、薬剤使用状態、つま
り薬剤の薬効成分残存量を使用者がはっきりと認識でき
る。According to the third aspect of the present invention, by observing the change in which the first mark disappears and the second mark appears as the heating time elapses, the medicine use state, that is, The user can clearly recognize the residual amount of the active ingredient of the drug.
【００１３】[0013]
【発明の実施の形態】図１に示すように、薬剤加熱蒸散
容器１と、薬剤含有体保持容器２と、薬剤含有体３で薬
剤加熱蒸散装置を形成する。前記薬剤加熱蒸散容器１
は、下部容器１０と上部容器１１をビス１２で連結した
形状である。前記下部容器１０は一側面に開口した薬剤
含有体挿入部１３と、この薬剤含有体挿入部１３の下部
を下面に開口する空気取入部１４を有し、発熱体１５が
取付けてある。この発熱体１５の最高表面温度は５０℃
〜２５０℃である。この発熱体１５の発熱面１５ａは水
平に対して斜めで、前記薬剤含有体挿入部１３に開口し
ている。前記下部容器１０にスイッチ部１６、押釦１
７、ランプ１８が取付けてある。この押釦１７を押すこ
とでスイッチ部１６がＯＮして発熱体１５に通電されて
発熱し、ランプ１８が点灯する。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS As shown in FIG. 1, a medicine heating and evaporation container 1, a medicine containing body holding container 2, and a medicine containing body 3 form a medicine heating and evaporation device. The chemical heating and evaporation container 1
Has a shape in which a lower container 10 and an upper container 11 are connected by screws 12. The lower container 10 has a medicine-containing body insertion portion 13 opened on one side, an air intake portion 14 having a lower portion of the medicine-containing body insertion portion 13 opened on the lower surface, and a heating element 15 is attached. The maximum surface temperature of the heating element 15 is 50 ° C.
２５０250 ° C. The heat generating surface 15a of the heat generating body 15 is oblique to the horizontal and opens to the medicine-containing body insertion portion 13. The lower container 10 has a switch unit 16 and a push button 1
7. Lamp 18 is installed. When the push button 17 is pressed, the switch section 16 is turned on, and the heating element 15 is energized to generate heat, and the lamp 18 is turned on.
【００１４】前記薬剤含有体保持容器２は、上面板２０
と下面板２１と前面板２２と後面板２３と両側面板２４
で略箱形状で、前面板２２に空気出口２５が形成され、
後面板２３に空気入口２６が形成してある。前記下面板
２１と前面板２２との間に隙間２７が有り、その下面板
２１は着脱自在である。この薬剤含有体保持容器２は、
薬剤含有体挿入部１３内に挿入され、下面板２１が発熱
体１５の発熱面１５ａに接すると共に、ストッパ１９に
当たる。The medicine-containing body holding container 2 includes an upper plate 20.
, Lower plate 21, front plate 22, rear plate 23, and both side plates 24
In a substantially box shape, an air outlet 25 is formed in the front plate 22,
An air inlet 26 is formed in the rear plate 23. There is a gap 27 between the lower plate 21 and the front plate 22, and the lower plate 21 is detachable. This medicine-containing body holding container 2 is
The lower surface plate 21 is inserted into the medicine-containing body insertion portion 13, and the lower surface plate 21 contacts the heat generating surface 15 a of the heat generating body 15 and hits the stopper 19.
【００１５】前記薬剤含有体３は加熱することで蒸散す
る薬剤が含浸された矩形板状で、前記下面板２１を外す
ことで薬剤含有体保持容器２内に設けられる。この薬剤
含有体３の内面と薬剤含有体３の表面との間に空気流通
用の隙間があり、発熱体１５を発熱することで矢印で示
すように空気が流れ、蒸散した薬剤がスムーズに拡散さ
れる。The medicine-containing body 3 is a rectangular plate impregnated with a medicine which evaporates when heated, and is provided in the medicine-containing body holding container 2 by removing the lower plate 21. There is a gap for air circulation between the inner surface of the drug-containing body 3 and the surface of the drug-containing body 3, and when the heating element 15 generates heat, air flows as shown by the arrow, and the evaporated drug is smoothly diffused. Is done.
【００１６】前記加熱することで蒸散する薬剤とは、発
熱体１５の最高温度が常温より５℃以上の時に空気中に
放出される薬剤である。この薬剤としては、殺虫剤、殺
ダニ剤、殺菌剤、防虫剤、芳香剤、消臭剤、害虫忌避剤
等である。The agent which evaporates by heating is an agent which is released into the air when the maximum temperature of the heating element 15 is 5 ° C. or higher than normal temperature. The chemicals include insecticides, acaricides, fungicides, insect repellents, fragrances, deodorants, insect repellents, and the like.
【００１７】前記薬剤含有体保持容器２の前面板２２に
インジケータ３０が取付けてある。このインジケータ３
０は薬剤含有体挿入部１３から目視可能である。An indicator 30 is attached to the front plate 22 of the medicine-containing container 2. This indicator 3
0 is visible from the medicine-containing body insertion portion 13.
【００１８】前記インジケータ３０は、加熱による不可
逆反応で起こる色変化を利用した薬剤使用期限を表示す
るもので、前記色変化によって視認可能なマークを視認
不可能なマークへ、視認不可能なマークを視認可能なマ
ークへの二つの変化を同時に起こす、すなわち２ヶ所以
上、色の視認変化を同時に起こすことで薬剤始点から薬
剤終点に到る経過とともに薬剤使用状態を表現するもの
である。詳しくは、加熱による不可逆反応で起こる色変
化を利用して始点色から終点色に色変化する変色部と、
この終点色で薬剤始点を表現する第１のマークと、前記
始点色で薬剤終点を表現する第２のマークを有するイン
ジケータである。The indicator 30 indicates the expiration date of a medicine utilizing a color change caused by an irreversible reaction due to heating. The mark which can be visually recognized due to the color change is changed to an invisible mark. Simultaneously causing two changes to the visually recognizable mark, that is, simultaneously causing two or more visual changes in color, expresses the drug use state along with the progress from the drug start point to the drug end point. Specifically, a discoloration portion that changes color from a start point color to an end point color using a color change caused by an irreversible reaction due to heating,
An indicator having a first mark expressing the medicine start point by the end point color and a second mark expressing the medicine end point by the start point color.
【００１９】前記変色部は、加熱時間の経過に伴って、
始点色から終点色に徐々に色変化する。これによって、
薬剤使用状態、つまり薬剤の薬効成分残存量を使用者が
はっきりと認識できる。The discolored portion, as the heating time elapses,
The color gradually changes from the start color to the end color. by this,
The user can clearly recognize the drug use state, that is, the remaining amount of the medicinal component of the drug.
【００２０】前記色変化の程度が、色差Δ（デルタ）Ｅ
＝１０以上である。これによって、見た目の視認性が良
い。つまり、前記色差がΔＥ＝１０以下であると見た目
の視認性が極端に落ちる。The degree of the color change is a color difference Δ (delta) E
= 10 or more. Thereby, the visual visibility is good. That is, when the color difference is equal to or less than ΔE = 10, the apparent visibility is extremely reduced.
【００２１】前記変色部の変色する最高温度は３５℃〜
２００℃である。The maximum temperature at which the discolored portion changes color is 35 ° C.
200 ° C.
【００２２】前記インジケータ３０の具体形状を図２に
基づいて説明する。ベース層３１と変色層３２と印刷層
３３を重ね合わせたフィルムラミネート構成で、印刷層
３３の表面にプレート３４が設けられる。前記ベース層
３１と変色層３２と印刷層３３は図２で分離して図示し
てあるが、これらはあらかじめ変色層３２を挟持する形
で重ね合わせて密着してある。この重ね合わせて密着し
たベース層３１、変色層３２、印刷層３３が前記薬剤含
有体保持容器２の前面板２２に形成した凹部２２ａに嵌
め込みして取付けられる。前記プレート３４は一対のピ
ン３４ａを有し、そのピン３４ａを前記前面板２２の孔
２２ｂに嵌合することで取付けられる。The specific shape of the indicator 30 will be described with reference to FIG. A plate 34 is provided on the surface of the print layer 33 in a film laminate configuration in which the base layer 31, the color change layer 32, and the print layer 33 are overlapped. The base layer 31, the color changing layer 32, and the printing layer 33 are separately illustrated in FIG. 2, but they are previously overlapped and adhered so as to sandwich the color changing layer 32. The base layer 31, the color change layer 32, and the print layer 33, which are closely attached to each other, are fitted and attached to the concave portions 22 a formed on the front plate 22 of the medicine-containing body holding container 2. The plate 34 has a pair of pins 34a, and is attached by fitting the pins 34a into the holes 22b of the front plate 22.
【００２３】前記ベース層３１は、隠蔽性の高い５０ミ
クロン以上の不透明フィルムを基材とする。このベース
層３１は、インジケータを設置したときの薬剤含有体保
持容器などの色の影響が、インジケータの色見に影響を
及ぼし難くするための隠蔽機能と、打ち抜きやカッティ
ングや整列、吸引、押出しといった製造に係わる基本物
性を調整する役割を有している。The base layer 31 is made of an opaque film having a high concealing property of 50 μm or more. The base layer 31 has a concealing function for preventing the influence of the color of the medicine-containing body holding container or the like when the indicator is installed from affecting the color appearance of the indicator, and punching, cutting, alignment, suction, and extrusion. It has the role of adjusting basic physical properties related to manufacturing.
【００２４】前記変色層３２は熱変色物質を保持する。
この変色層３２が変色部である。前記変色層３２の変色
前の色（始点色）はベース層３１と同じ色である。The color changing layer 32 holds a thermochromic substance.
The color changing layer 32 is a color changing portion. The color (starting point color) of the color changing layer 32 before the color changing is the same color as that of the base layer 31.
【００２５】前記熱変色物質としては、例えば混合もし
くは接触により呈色反応もしくは変色反応を示す２つの
薬剤の一方を含浸もしくは被覆させた支持体あるいは皮
膜形成成分中に溶解もしくは分解させて得られる皮膜で
ある第１層、第１層上に設けられた所望温度にて２つの
薬剤の少なくとも一方を拡散移行せしめる樹脂皮膜であ
る第２層および第２層上に設けられたもう一方の薬剤を
含む第３層からなり、前記呈色反応もしくは変色反応
は、酸塩基物質あるいは酸塩基指示薬、酸化−還元剤お
よび酸化還元指示剤、金属化合物とキレート化剤などの
混合もしくは接触により起き、前記第１層と第３層を隔
てる加熱により拡散移行せしめる第２層である樹脂皮膜
は、ポリエステル、ポリアミド、アクリル系樹脂である
熱変色性積層物が用いられる。Examples of the thermochromic substance include, for example, a film obtained by dissolving or decomposing a substrate or a film-forming component impregnated or coated with one of two agents exhibiting a color reaction or a color change reaction by mixing or contact. A first layer provided on the first layer, a second layer which is a resin film for diffusing and transferring at least one of the two agents at a desired temperature, and the other agent provided on the second layer. The color reaction or the color change reaction is caused by mixing or contacting an acid-base substance or an acid-base indicator, an oxidation-reduction agent and an oxidation-reduction indicator, a metal compound and a chelating agent, and the first layer. The resin film, which is the second layer that transfers and diffuses by heating that separates the layer and the third layer, is made of a thermochromic laminate of polyester, polyamide, or acrylic resin. It is.
【００２６】前記印刷層３３は５〜３０ミクロンの透明
フィルムを基材とする。この透明フィルム、一般的には
裏面（変色層３２側の面）に表示マークが印刷されてい
る。前記透明フィルムは変色層３２の保護機能、適度な
酸素透過機能を有する。The printing layer 33 has a transparent film of 5 to 30 microns as a base material. An indication mark is printed on the transparent film, generally on the back surface (the surface on the side of the color changing layer 32). The transparent film has a function of protecting the color changing layer 32 and an appropriate function of transmitting oxygen.
【００２７】前記プレート３４は透明フィルムで、紫外
線吸収剤が混合してある。このプレート３４で紫外線が
変色層３２に当たることを防止し、紫外線で変色しない
ようにしてある。また、印刷層３３の基材フィルムに紫
外線吸収剤をねり込み、又は塗布することもできる。The plate 34 is a transparent film mixed with an ultraviolet absorber. The plate 34 prevents ultraviolet rays from hitting the discoloration layer 32 so that the plate 34 does not discolor. In addition, an ultraviolet absorber can be incorporated or applied to the base film of the printing layer 33.
【００２８】次に第１の具体例を説明する。ベース層３
１は白色である。変色層３２は変色前が白色で、変色後
が赤色である。印刷層３３には図２に示すように、赤色
で「はじめ」の文字（つまり、薬剤始点を表現する第１
のマーク）、白色で「おわり」の文字（つまり、薬剤終
点を表現する第２のマーク）、「はじめ」の文字から
「おわり」の文字に向う矢印が印刷してある。前記矢印
は「はじめ」の文字側部が赤色で、「おわり」の文字に
向けて順次色がうすくなり、「おわり」の文字側部が白
色のグラデーション印刷である。Next, a first specific example will be described. Base layer 3
1 is white. The color change layer 32 is white before the color change and red after the color change. As shown in FIG. 2, the print layer 33 has a red “beginning” character (that is, a first character representing a medicine starting point).
), A white “End” character (ie, a second mark representing the end point of the medicine), and an arrow from the “First” character to the “End” character are printed. The arrow is a gradation print in which the characters at the beginning of the arrow are red, the color gradually fades toward the characters at the end, and the characters at the end of the end are white.
【００２９】インジケータ３０の薬剤加熱蒸散開始時
は、図３（ａ）に示すように、「はじめ」の文字と「は
じめ」の文字寄りの矢印が視認できる外観である。薬剤
加熱時間の経過とともに図３（ｂ）に示すように変色層
３２がうすい赤色に変色し、「おわり」の文字がぼんや
りと視認できる外観となる。前記「おわり」の文字と変
色層３２の赤色の濃淡の差は小である。薬剤加熱時間が
さらに経過すると図３（ｃ）に示すように変色層３２が
やや濃い赤色に変色し、「おわり」の文字がややはっき
りと視認できる外観となる。As shown in FIG. 3 (a), when the chemical heating and evaporation of the indicator 30 is started, the character of "start" and the arrow near the character of "start" can be visually recognized. As shown in FIG. 3 (b), the color of the discoloration layer 32 changes to a slightly red color with the elapse of the heating time of the medicine, so that the appearance of the character "END" is faintly visible. The difference between the letters "end" and the shade of red of the discoloration layer 32 is small. When the medicine heating time further elapses, the discoloring layer 32 discolors to a slightly deeper red color as shown in FIG. 3 (c), and the appearance of the character "END" becomes somewhat clear.
【００３０】このように外観が変化するので、「はじ
め」の文字と変色層３２の赤色の濃淡の差によって、薬
剤加熱時間、つまり薬剤含有体３に含有されている薬剤
の残量を使用者が認識できる。Since the appearance changes in this way, the heating time of the medicine, that is, the remaining amount of the medicine contained in the medicine containing body 3 is determined by the user based on the difference between the character of “beginning” and the shade of red of the discoloration layer 32. Can be recognized.
【００３１】薬剤加熱時間が終了して薬剤終了、つまり
薬剤含有体３に含有されている薬剤の残量が有効量を下
回った時は、図３（ｄ）に示すように「はじめ」の文字
の赤色と変色層３２の赤色が同じ濃度となるので、「は
じめ」の文字は視認できずに「おわり」の文字がはっき
りと視認できる外観となる。When the medicine heating time ends and the medicine ends, that is, when the remaining amount of the medicine contained in the medicine containing body 3 falls below the effective amount, as shown in FIG. And the red color of the discoloration layer 32 have the same density, so that the appearance of the characters "end" is clearly visible without the characters of "beginning" being visible.
【００３２】このようであるから、使用者は薬効成分が
消滅したことをはっきりと認識することができる。As described above, the user can clearly recognize that the medicinal component has disappeared.
【００３３】次に第２の具体例を説明する。ベース層３
１は白色である。変色層３２は変色前が白色で、変色後
が赤色である。印刷層３３には図４（ａ）に示すよう
に、赤色で「はじめ」の文字、白色で「おわり」の文
字、白色の第１帯状部３５、うすい赤色の第２帯状部３
６、やや濃い赤色の第３帯状部３７、「はじめ」の文字
と同じ濃さの赤色の第４帯状部３８が連続して印刷して
ある。Next, a second specific example will be described. Base layer 3
1 is white. The color change layer 32 is white before the color change and red after the color change. As shown in FIG. 4A, the print layer 33 has a red “start” character, a white “end” character, a white first band portion 35, and a light red second band portion 3.
6, a third band 37 of slightly dark red and a fourth band 38 of red having the same darkness as the character of "beginning" are continuously printed.
【００３４】薬剤加熱開始時は、図４（ａ）に示すよう
に、「はじめ」の文字と第２・第３・第４帯状部３６，
３７，３８が視認できる外観である。薬剤加熱時間の経
過とともに図４（ｂ）に示すように、変色層３２がうす
い赤色に変色し、第１・第３・第４帯状部３５，３７，
３８が視認できると共に、第２帯状部３６が視認できな
くなる。薬剤加熱時間がさらに経過すると図４（ｃ）に
示すように、変色層３２がやや濃い赤色に変色し、第１
・第２・第４帯状部３５，３６，３８が視認され、第３
帯状部３７が視認できなくなる。At the start of heating of the medicine, as shown in FIG. 4 (a), the characters "beginning" and the second, third and fourth strips 36,
37 and 38 are visible appearances. As shown in FIG. 4 (b), the color of the discoloration layer 32 changes to light red with the passage of the heating time of the medicine, and the first, third, and fourth strips 35, 37,
38 can be visually recognized, and the second band portion 36 cannot be visually recognized. When the medicine heating time further elapses, as shown in FIG. 4 (c), the discoloration layer 32 discolors to a slightly deeper red color,
-The second and fourth belt-like portions 35, 36, 38 are visually recognized, and the third
The belt-shaped portion 37 cannot be visually recognized.
【００３５】薬剤加熱時間が終了して薬剤終了した時に
は、図４（ｄ）に示すように、「おわり」の文字と第１
・第２・第３帯状部３５，３６，３７が視認でき、第４
帯状部３８が視認できなくなる。When the medicine heating time is over and the medicine is finished, as shown in FIG.
-The second and third belt-like portions 35, 36, 37 can be visually recognized, and the fourth
The strip 38 becomes invisible.
【００３６】このように、薬剤加熱時間を第１・第２・
第３・第４帯状部３５，３６，３７，３８を視認するこ
とで認識できる。なお、「はじめ」の文字、「おわり」
の文字の視認は第１の具体例と同様に変化する。As described above, the medicine heating time is set to the first, second, and third times.
The third and fourth belt portions 35, 36, 37, 38 can be recognized by visual recognition. In addition, the character of "the beginning", "end"
The visual recognition of the character changes as in the first specific example.
【００３７】次に第３の具体例を説明する。図５に示す
ように、透明なフィルムより成る印刷層３３の左半分３
３ａを「す」の文字形を除いて、赤色に印刷し、右半分
３３ｂを「せん」の文字形を除いて白色に印刷する。前
記左半分３３ａの赤色印刷層の中で透明に抜かれた
「す」の文字の前に、更に白色で「使用できま」の文字
を印刷する。Next, a third specific example will be described. As shown in FIG. 5, the left half 3 of the print layer 33 made of a transparent film is used.
3a is printed in red, excluding the character shape of "su", and the right half 33b is printed in white, excluding the character shape of "sen". In front of the transparently drawn "su" character in the red printing layer of the left half 33a, a white "usable" character is further printed.
【００３８】薬剤加熱開始時には図６（ａ）に示すよう
に、「使用できます」の文字が視認できる。薬剤加熱時
間の経過とともに変色層３２が赤色に徐々に変色するの
で、図６（ｂ）、図６（ｃ）に示すように「す」の文字
が徐々にうすく視認され、「せん」の文字が徐々にはっ
きりと視認される外観となる。At the start of heating of the medicine, as shown in FIG. The color of the discoloration layer 32 gradually changes to red with the elapse of the heating time of the medicine, so that the letters “su” are gradually visually recognized as shown in FIGS. 6B and 6C, and the letters “sen” are displayed. Gradually becomes clearly visible.
【００３９】薬剤加熱時間が終了し薬剤終了すると、図
６（ｄ）に示すように「す」の文字が視認できずに、
「せん」の文字がはっきりと視認できる外観となるの
で、使用者は「使用できません」の文字を視認できる。When the medicine heating time ends and the medicine ends, as shown in FIG.
Since the appearance of the character "sen" is clearly visible, the user can visually recognize the character "unavailable".
【００４０】前記インジケータ３０は薬剤加熱蒸散容器
１の発熱体１５の近くで外部から目視可能な位置を設け
るのが好ましい。It is preferable that the indicator 30 be provided at a position near the heating element 15 of the medicine heating and vaporizing container 1 so as to be visible from the outside.
【００４１】[0041]
【発明の効果】請求項１に係る発明によれば、２ヶ所以
上、色の視認変化を起こすので、薬剤終点となって薬効
成分が消滅したことを使用者がはっきりと認識できる。According to the first aspect of the present invention, the color is visually changed at two or more places, so that the user can clearly recognize that the medicinal component has disappeared at the end point of the medicine.
【００４２】請求項２に係る発明によれば、第１のマー
クと第２のマークの色の視認変化で薬剤終点となって薬
効成分が消滅したことを使用者がはっきりと認識でき
る。According to the second aspect of the present invention, the user can clearly recognize that the medicinal component has disappeared as the end point of the medicine due to the visual change of the colors of the first mark and the second mark.
【００４３】請求項３に係る発明によれば、加熱時間の
経過に伴って、徐々に一つのマークが消滅していき、他
方のマークが現出してくる変化を観察することで、薬剤
使用状態、つまり薬剤の薬効成分残存量を使用者がはっ
きりと認識できる。According to the third aspect of the present invention, by observing a change in which one mark gradually disappears and the other mark appears as the heating time elapses, the state of use of the medicine is improved. That is, the user can clearly recognize the remaining amount of the medicinal component of the drug.
【図１】薬剤加熱蒸散装置の断面図である。FIG. 1 is a sectional view of a chemical heating and evaporating apparatus.
【図２】インジケータの取付部とインジケータの分解斜
視図である。FIG. 2 is an exploded perspective view of the indicator mounting portion and the indicator.
【図３】インジケータの第１の具体例の色変化説明図で
ある。FIG. 3 is an explanatory diagram of a color change of a first specific example of an indicator.
【図４】インジケータの第２の具体例の色変化説明図で
ある。FIG. 4 is an explanatory diagram of a color change of a second specific example of the indicator.
【図５】インジケータの第３の具体例における印刷層の
斜視図である。FIG. 5 is a perspective view of a printed layer in a third specific example of the indicator.
【図６】第３の具体例の色変化説明図である。FIG. 6 is an explanatory diagram of a color change in a third specific example.
１…薬剤加熱蒸散容器、２…薬剤含有体保持容器、３…
薬剤含有体、１５…発熱体、３０…インジケータ、３１
…ベース層、３２…変色層、３３…印刷層。DESCRIPTION OF SYMBOLS 1 ... Drug heating evaporation container, 2 ... Drug-containing body holding container, 3 ...
Drug-containing substance, 15: heating element, 30: indicator, 31
... Base layer, 32. Color changing layer, 33. Printing layer.
Claims (4)
利用した薬剤使用期限を表示するインジケータであっ
て、前記色変化によって、視認可能なマークを視認不可
能なマークへ、視認不可能なマークを視認可能なマーク
へ、の二つの変化を同時に起こすことで、薬剤始点から
薬剤終点に到る経過とともに薬剤使用状態を表現するこ
とを特徴とする加熱蒸散薬剤用インジケータ。1. An indicator for displaying a drug expiration date utilizing a color change caused by an irreversible reaction due to heating, wherein a mark that can be visually recognized is changed to a mark that cannot be visually recognized by the color change. An indicator for a heat-evaporated medicine, characterized by expressing the use state of the medicine with the progress from the medicine start point to the medicine end point by simultaneously causing two changes to the visible mark.
のマークが薬剤終点色で表現され、視認不可能から視認
可能へ変化する第２のマークが薬剤始点色で表現された
ことを特徴とする請求項１記載の加熱蒸散薬剤用インジ
ケータ。2. A first method for changing from visible to invisible.
2. The indicator for a heat-evaporated medicine according to claim 1, wherein the mark is represented by a medicine end point color, and the second mark, which changes from invisible to visible, is represented by a medicine start point color.
経過に伴って徐々に進行することを特徴とする請求項１
又は請求項２記載の加熱蒸散薬剤用インジケータ。3. The method according to claim 1, wherein the color change is not sudden but progresses gradually with the elapse of the heating time.
Alternatively, the indicator for a heat-evaporated drug according to claim 2.
で、表側に、５〜３０ミクロンの透明フィルムを基材と
した印刷層、裏側に隠蔽性の高い５０ミクロン以上の不
透明フィルムを基材としたベース層でフィルムラミネー
ト構成とした請求項１記載の加熱蒸散薬剤用インジケー
タ。4. A printing layer based on a transparent film of 5 to 30 μm on the front side and an opaque film of 50 μm or more having a high concealment property on the back side, sandwiching a color changing layer holding a color changing substance. 2. The indicator for a heat-evaporated medicine according to claim 1, wherein the base layer is a film laminated structure.
Priority Applications (24)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001199091A JP4766638B2 (en) | 2001-01-29 | 2001-06-29 | Indicator for heating transpiration drug |
| CA002473552A CA2473552A1 (en) | 2001-01-29 | 2001-09-06 | Whole heated, chemical containing body, chemical containing body retaining receptacle, chemical heating, volatilizing apparatus and indicator for a heat volatilizing chemical |
| PCT/JP2001/007728 WO2002060254A1 (en) | 2001-01-29 | 2001-09-06 | Chemical-containing formed material of type of heating of whole the material, container for holding chemical-containing formed material, device for heating and transpiring chemical and indicator for chemical to be heated and vaporized |
| KR1020037008234A KR100746520B1 (en) | 2001-01-29 | 2001-09-06 | Chemical heating, volatilizing apparatus |
| AT01963465T ATE505080T1 (en) | 2001-01-29 | 2001-09-06 | DEVICE FOR HEATING AND VAPORIZING A CHEMICAL |
| IL156333A IL156333A (en) | 2001-01-29 | 2001-09-06 | Chemical-containing formed material of type enabling heating of the whole material, container for holding the chemical-containing formed material, device for heating and vaporizing the chemical and indicator of quantity of chemical to be heated and vaporized |
| CNB018217141A CN1291647C (en) | 2001-01-29 | 2001-09-06 | Chemical-containing formed material of type of heating of whole the material container for holding chemical-containing formed matzrial device for |
| AU2001284452A AU2001284452B2 (en) | 2001-01-29 | 2001-09-06 | Whole-heated, chemical containing body, chemical containing body retaining receptacle, chemical heating, volatilizing apparatus and indicator for a heat volatilizing chemical |
| US10/433,519 US7449154B2 (en) | 2001-01-29 | 2001-09-06 | Chemical-containing formed material of type of heating of whole the material, container for holding chemical-containing formed material, device for heating and transpiring chemical and indicator for chemical to be heated and vaporized |
| EP01963465A EP1356731B1 (en) | 2001-01-29 | 2001-09-06 | Apparatus for heating and volatilizing a chemical |
| NZ526268A NZ526268A (en) | 2001-01-29 | 2001-09-06 | Chemical-containing formed material of type of heating of whole the material, container for holding chemical- containing formed material, device for heating and transpiring chemical and indicator for chemical to be heated and vaporized |
| PL01363451A PL363451A1 (en) | 2001-01-29 | 2001-09-06 | Chemical-containing formed material of type of heating of whole the material, container for holding chemical-containing formed material, device for heating and transpiring chemical and indicator for chemical to be heated and vaporized |
| HU0303003A HU228096B1 (en) | 2001-01-29 | 2001-09-06 | Chemical-containing formed material of type of heating of whole the material container for holding chemical-containing formed material, device for heating and transpiring chemical and indicator for chemical to be heated and vaporized |
| MXPA03006740A MXPA03006740A (en) | 2001-01-29 | 2001-09-06 | Chemical-containing formed material of type of heating of whole the material, container for holding chemical-containing formed material, device for heating and transpiring chemical and indicator for chemical to be heated and vaporized. |
| BRPI0116528-3A BR0116528B1 (en) | 2001-01-29 | 2001-09-06 | chemical volatilization body, chemical heating volatilization apparatus, and, indicator for a heat volatilization chemical. |
| DE60144442T DE60144442D1 (en) | 2001-01-29 | 2001-09-06 | DEVICE FOR HEATING AND EVAPORATING A CHEMICAL |
| TW090126077A TWI225772B (en) | 2001-01-29 | 2001-10-22 | Chemical-transpiring body, device for heating and transpiring chemical and indicator for chemical to be heated and vaporized |
| ARP010105057A AR031166A1 (en) | 2001-01-29 | 2001-10-29 | BODY CONTAINING COMPLETELY WARMED CHEMICAL AGENT, BODY RETENTION RECEPTURE CONTAINING CHEMICAL AGENT, HEATING AND VOLATILIZATION DEVICE OF CHEMICAL AGENT AND INDICATOR FOR A CHEMICAL AGENT VOLATILIZABLE BY HEAT |
| MYPI20015024A MY136846A (en) | 2001-01-29 | 2001-10-30 | Whole heated, chemical containing body, chemical containing body retaining receptacle, chemical heating, volatilizing apparatus and indicator for a heat volatilizing chemical |
| PE2001001109A PE20020725A1 (en) | 2001-01-29 | 2001-11-08 | BODY CONTAINING FULLY HEATED CHEMICAL AGENT, RETENTION RECEPTACLE, BODY CONTAINING CHEMICAL AGENT, CHEMICAL AGENT VOLATILIZATION AND HEATING APPARATUS AND INDICATOR FOR A HEAT VOLATILIZABLE CHEMICAL AGENT |
| EG20011189A EG23053A (en) | 2001-01-29 | 2001-11-10 | Whole heated chemical containing body chemical containing body retaining receptacle chemical heatingvolatilizing apparatus and indicator for a heat v olatilizing chemical |
| GCP20021829 GC0000383A (en) | 2001-01-29 | 2002-01-26 | Whole heated, chemical containing body, chemical containing body retaining receptacle, chemical heating, volatilizing apparatus and indicator for a heat volatilizing chemical |
| HR20030529A HRP20030529A2 (en) | 2001-01-29 | 2003-06-27 | Chemical-containing formed material of type of heating of whole the material, container for holding |
| HK03109171.9A HK1056666A1 (en) | 2001-01-29 | 2003-12-16 | Apparatus for heating and volatilizing a chemical |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001020007 | 2001-01-29 | ||
| JP2001020007 | 2001-01-29 | ||
| JP2001-20007 | 2001-01-29 | ||
| JP2001199091A JP4766638B2 (en) | 2001-01-29 | 2001-06-29 | Indicator for heating transpiration drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002293703A true JP2002293703A (en) | 2002-10-09 |
| JP4766638B2 JP4766638B2 (en) | 2011-09-07 |
Family
ID=26608435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001199091A Expired - Fee Related JP4766638B2 (en) | 2001-01-29 | 2001-06-29 | Indicator for heating transpiration drug |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4766638B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005016284A (en) * | 2003-06-02 | 2005-01-20 | Kao Corp | Chemical solution discharge container |
| JP2005036495A (en) * | 2003-07-15 | 2005-02-10 | Kao Corp | Chemical discharging container |
| JP2009525394A (en) * | 2006-02-03 | 2009-07-09 | エス．シー． ジョンソン アンド サン、インコーポレイテッド | Air treatment device with a single-use indicator |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0618676A (en) * | 1992-07-02 | 1994-01-28 | Sumitomo Chem Co Ltd | Time indicator |
| JPH0789806A (en) * | 1993-09-21 | 1995-04-04 | Fumakilla Ltd | Method for thermally transpiring chemical agent |
| JPH07260955A (en) * | 1994-03-18 | 1995-10-13 | Toppan Printing Co Ltd | Time passage display unit |
| JPH11302103A (en) * | 1998-04-24 | 1999-11-02 | Earth Chem Corp Ltd | Thermal fumigation |
| JP2001151605A (en) * | 1999-11-30 | 2001-06-05 | S T Chem Co Ltd | Volatillizer of chemical and indicator |
-
2001
- 2001-06-29 JP JP2001199091A patent/JP4766638B2/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0618676A (en) * | 1992-07-02 | 1994-01-28 | Sumitomo Chem Co Ltd | Time indicator |
| JPH0789806A (en) * | 1993-09-21 | 1995-04-04 | Fumakilla Ltd | Method for thermally transpiring chemical agent |
| JPH07260955A (en) * | 1994-03-18 | 1995-10-13 | Toppan Printing Co Ltd | Time passage display unit |
| JPH11302103A (en) * | 1998-04-24 | 1999-11-02 | Earth Chem Corp Ltd | Thermal fumigation |
| JP2001151605A (en) * | 1999-11-30 | 2001-06-05 | S T Chem Co Ltd | Volatillizer of chemical and indicator |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005016284A (en) * | 2003-06-02 | 2005-01-20 | Kao Corp | Chemical solution discharge container |
| JP4548570B2 (en) * | 2003-06-02 | 2010-09-22 | 花王株式会社 | Chemical discharge container |
| JP2005036495A (en) * | 2003-07-15 | 2005-02-10 | Kao Corp | Chemical discharging container |
| JP4548569B2 (en) * | 2003-07-15 | 2010-09-22 | 花王株式会社 | Chemical discharge container |
| JP2009525394A (en) * | 2006-02-03 | 2009-07-09 | エス．シー． ジョンソン アンド サン、インコーポレイテッド | Air treatment device with a single-use indicator |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4766638B2 (en) | 2011-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5633836A (en) | Accelerated development time-delayed message system | |
| US5633835A (en) | Long term rapid color changing time indicator | |
| US4292916A (en) | Timer and storage condition indicator | |
| KR101296010B1 (en) | Solvatochromic Visual Indicator and the Use of the Same | |
| US4408557A (en) | Timer and storage condition indicator | |
| US5602804A (en) | Long term rapid color changing time indicator | |
| EP0772802B1 (en) | Time indicator having discrete adhesive | |
| US5822280A (en) | Long term rapid color changing time indicator employing dye absorbing layer | |
| US20050037498A1 (en) | Plural intrinsic expiration initiation application indicators | |
| BRPI0913415B1 (en) | indicator system | |
| NO865065L (en) | LONG-TERM INDICATOR DEVICE AND PRODUCTS CONTAINING SUCH A DEVICE. | |
| WO2007075418A2 (en) | Three-dimensional dye migration time indicator | |
| JP2002293703A (en) | Indicator for heat-evaporation agent | |
| KR100746520B1 (en) | Chemical heating, volatilizing apparatus | |
| JP3940646B2 (en) | Heating transpiration device and heating transpiration method | |
| JP2023540103A (en) | multilayer colorimetric indicator | |
| JPH0466518B2 (en) | ||
| TWI263040B (en) | Adjustable irreversible temperature alarm device | |
| JPH0348604Y2 (en) | ||
| JPH09117243A (en) | Volatilizing material of chemical agent liquid also used as indicator, and chemical agent liquid-volatilizing device using the same material and also used as the indicator | |
| JP2003275233A (en) | Discoloring gel sheet | |
| JPS62235562A (en) | Indicator for indirect chemical efficacy end point | |
| NZ247006A (en) | Disposable elapsed time indicator of laminated strip form: seal between reservoir and absorbent sponge is ruptured to activate indicator | |
| JP3085041U (en) | Insect repellent with lottery | |
| JPH06262882A (en) | Form with perfume-in card |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071217 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20100217 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101215 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110207 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110413 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110414 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110608 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110613 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4766638 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140624 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |